Ryan M Tobin, Shikha Singh, Sudhir Kumar, Sayaka Miura
{"title":"GenoPath:一个从肿瘤DNA测序数据推断肿瘤克隆组成、突变历史和转移细胞迁移事件的管道。","authors":"Ryan M Tobin, Shikha Singh, Sudhir Kumar, Sayaka Miura","doi":"10.3389/fbinf.2025.1615834","DOIUrl":null,"url":null,"abstract":"<p><p>DNA sequencing technologies are widely used to study tumor evolution within a cancer patient. However, analyses require various computational methods, including those to infer clone sequences (genotypes of cancer cell populations), clone frequencies within each tumor sample, clone phylogeny, mutational tree, dynamics of mutational signatures, and metastatic cell migration events. Therefore, we developed GenoPath, a streamlined pipeline of existing tools to perform tumor evolution analysis. We also developed and added tools to visualize results to assist interpretation and derive biological insights. We have illustrated GenoPath's utility through a case study of tumor evolution using metastatic prostate cancer data. By reducing computational barriers, GenoPath broadens access to tumor evolution analysis. The software is available at https://github.com/SayakaMiura/GP.</p>","PeriodicalId":73066,"journal":{"name":"Frontiers in bioinformatics","volume":"5 ","pages":"1615834"},"PeriodicalIF":3.9000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263698/pdf/","citationCount":"0","resultStr":"{\"title\":\"GenoPath: a pipeline to infer tumor clone composition, mutational history, and metastatic cell migration events from tumor DNA sequencing data.\",\"authors\":\"Ryan M Tobin, Shikha Singh, Sudhir Kumar, Sayaka Miura\",\"doi\":\"10.3389/fbinf.2025.1615834\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>DNA sequencing technologies are widely used to study tumor evolution within a cancer patient. However, analyses require various computational methods, including those to infer clone sequences (genotypes of cancer cell populations), clone frequencies within each tumor sample, clone phylogeny, mutational tree, dynamics of mutational signatures, and metastatic cell migration events. Therefore, we developed GenoPath, a streamlined pipeline of existing tools to perform tumor evolution analysis. We also developed and added tools to visualize results to assist interpretation and derive biological insights. We have illustrated GenoPath's utility through a case study of tumor evolution using metastatic prostate cancer data. By reducing computational barriers, GenoPath broadens access to tumor evolution analysis. The software is available at https://github.com/SayakaMiura/GP.</p>\",\"PeriodicalId\":73066,\"journal\":{\"name\":\"Frontiers in bioinformatics\",\"volume\":\"5 \",\"pages\":\"1615834\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263698/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in bioinformatics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/fbinf.2025.1615834\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MATHEMATICAL & COMPUTATIONAL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fbinf.2025.1615834","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MATHEMATICAL & COMPUTATIONAL BIOLOGY","Score":null,"Total":0}
GenoPath: a pipeline to infer tumor clone composition, mutational history, and metastatic cell migration events from tumor DNA sequencing data.
DNA sequencing technologies are widely used to study tumor evolution within a cancer patient. However, analyses require various computational methods, including those to infer clone sequences (genotypes of cancer cell populations), clone frequencies within each tumor sample, clone phylogeny, mutational tree, dynamics of mutational signatures, and metastatic cell migration events. Therefore, we developed GenoPath, a streamlined pipeline of existing tools to perform tumor evolution analysis. We also developed and added tools to visualize results to assist interpretation and derive biological insights. We have illustrated GenoPath's utility through a case study of tumor evolution using metastatic prostate cancer data. By reducing computational barriers, GenoPath broadens access to tumor evolution analysis. The software is available at https://github.com/SayakaMiura/GP.